Chantel Hillestad
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Incyte Corporation accounts for 76.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $5,436, more than ten times the $13 reported in 2022. Among family clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $93.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$5K
- AbbVie$299
- Regeneron Healthcare Solutions, Inc.$242
- Lilly USA, LLC$200
- Arcutis Biotherapeutics, Inc.$190
- Sanofi$159
- plus $357 from 6 others
What the payments were for
- Consulting fees$2,93348%
- Travel & lodging$1,43524%
- Food & beverage$1,65927%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 15 | $4,644 |
| AbbVie | 21 | $299 |
| Regeneron Healthcare Solutions, Inc. | 2 | $242 |
| Lilly USA, LLC | 8 | $200 |
| Arcutis Biotherapeutics, Inc. | 1 | $190 |
| Sanofi | 2 | $159 |
| Johnson & Johnson | 5 | $144 |
| Amgen | 5 | $101 |
| Novartis | 3 | $60 |
| Organon | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,092 in reported general payments places this provider in the 95th percentile of 496 family providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinolone Acetonide | 47 | $2,462 |
| Tretinoin | 24 | $2,413 |
| Ketoconazole | 151 | $2,281 |
| Metronidazole | 30 | $1,747 |
| Tacrolimus | 23 | $1,611 |
| Doxycycline Hyclate | 32 | $1,514 |
| Triamcinolone Acetonide | 66 | $1,062 |
| Clobetasol Propionate | 12 | $941 |
| Nystatin | 26 | $578 |
| Mupirocin | 46 | $362 |
Paid to pharmacies, not to this prescriber.
Other family in Minot
- Kevin ClemansMinot$4K
- Jennifer BurmanMinot$3K
- Lynette VondalMinot$3K
- Danna BossertMinot$3K
- Ashley WallnerMinot$2K
- Ann WelchMinot$2K
- Amanda WeidlerMinot$2K
- Robin PursifullMinot$1K
- Christina DahlJamestown$26K
- Coralyn Jensen KurtzGrand Forks$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.